Van Hulzen Asset Management LLC Has $3.01 Million Stock Position in UnitedHealth Group Incorporated $UNH

Key Points

• Van Hulzen Asset Management LLC has significantly reduced its stake in UnitedHealth Group, decreasing its position by 74.2% to hold 5,750 shares worth approximately $3.01 million.
• Several other hedge funds have increased their positions in UnitedHealth Group, with Brighton Jones LLC leading at a 176.2% increase, now holding 44,249 shares valued at $22.38 million.
• UnitedHealth Group's recent quarterly earnings reported an EPS of $4.08, missing analysts' estimates, and they announced a quarterly dividend of $2.21 per share, reflecting a dividend yield of 2.9%.

Van Hulzen Asset Management LLC reduced its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 74.2% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 5,750 shares of the healthcare conglomerate's stock after selling 16,531 shares during the period. Van Hulzen Asset Management LLC's holdings in UnitedHealth Group were worth $3,011,000 as of its most recent filing with the SEC.

Other hedge funds have also bought and sold shares of the company. Brighton Jones LLC lifted its position in UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after acquiring an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC increased its holdings in shares of UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after purchasing an additional 2,324 shares during the period. MGO One Seven LLC increased its holdings in shares of UnitedHealth Group by 17.5% during the fourth quarter. MGO One Seven LLC now owns 8,751 shares of the healthcare conglomerate's stock worth $4,427,000 after purchasing an additional 1,306 shares during the period. RiverPark Advisors LLC increased its stake in UnitedHealth Group by 2.6% in the fourth quarter. RiverPark Advisors LLC now owns 7,051 shares of the healthcare conglomerate's stock valued at $3,570,000 after acquiring an additional 180 shares during the last quarter. Finally, Burling Wealth Partners LLC bought a new position in UnitedHealth Group in the fourth quarter valued at approximately $4,740,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

UNH has been the topic of a number of recent analyst reports. TD Cowen cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price objective on the stock. in a research note on Monday, May 19th. Bank of America boosted their target price on shares of UnitedHealth Group from $290.00 to $325.00 and gave the stock a "neutral" rating in a research note on Monday. Baird R W cut shares of UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research note on Thursday, July 31st. Deutsche Bank Aktiengesellschaft cut their price target on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a report on Wednesday, May 14th. Finally, Robert W. Baird reiterated an "underperform" rating and set a $198.00 price target (down previously from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Fifteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of "Moderate Buy" and an average price target of $365.38.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $303.4150 on Friday. The firm's 50-day moving average price is $288.51 and its 200-day moving average price is $391.21. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The firm has a market capitalization of $274.79 billion, a P/E ratio of 13.15, a P/E/G ratio of 1.93 and a beta of 0.43. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the prior year, the company posted $6.80 EPS. UnitedHealth Group's revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's dividend payout ratio is currently 38.30%.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer owned 10,398 shares in the company, valued at $3,171,390. This represents a 5.36% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.28% of the stock is owned by corporate insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.